Naringin can reduce the inflammatory response in colonic tissues by upregulating the levels of SOD and GSH, reducing the levels of MDA and MPO, thus improving the TNBS-induced pathological changes in colitis (Cao et al., 2018; Hambardikar and Mandlik, 2022). Here, MPO is linked to colitis.